Diabetes and urine chemistry boost Bayer's diagnostics unit
This article was originally published in Clinica
Executive Summary
German company Bayer attributes the 9% rise in diagnostics sales last year to good performance in the diabetes and urine chemistry business units. The division had revenues of DM 1,639 million ($1,093 million).